Author

A. A. Lehmann

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

P. A. Reche· 2 shared P. V. Lehmann· 2 shared T. Zhang· 2 shared M. Suwansaard· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

P. A. Reche

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CERI, CEFX, and CPI: largely improved positive controls for testing antigen-specific T cell function in PBMC compared to CEF

A. A. Lehmann, P. A. Reche, T. Zhang, M. Suwansaard, P. V. Lehmann

The paper introduces improved positive controls (CERI, CEFX, CPI) for assessing T cell function in PBMC compared to CEF peptides, showing CEF's limitations in CD8+ T cell and APC evaluation.

bioRxiv · Nov 12, 2020Immunology

Discordance between the predicted vs. the actually recognized CD8+ T cell epitopes of HCMV pp65 antigen and aleatory epitope dominance

A. A. Lehmann, T. Zhang, P. A. Reche, P. V. Lehmann

The paper compares predicted and actual CD8+ T cell epitopes for HCMV pp65 antigen across ten HLA-A*02:01-matched individuals, finding no correlation between predicted epitope rankings and actual immune dominance.

bioRxiv · Nov 6, 2020Immunology